夏阳先生有超过30年的医药领域从业经历，职业经验涵盖新药研发; 药品生产、销售; 医疗器械及保健品的研发、生产、销售; 大型药企的经营管理等。对国内医疗医药行业的发展、国家药政法规、国内外创新药物的研发方向、医药企业的运营管理、大型医药企业的并购及整合具有深刻的理解及丰富的经验。

夏阳先生曾先后担任武汉人福科技股份有限公司总裁助理, 人福医药销售有限公司总经理，中国专家集团(美国OTCBB)副总裁, 北京紫华康泰医药有限公司董事总经理，Frost &Sullivan中国区医疗部副总经理，华润东阿投资有限公司总裁助理, 北京华达杰瑞生物技术有限公司董事总经理。

Mr. Yang Xia has over 30 years experience in medical industry, specialized in R&D, manufacturing and sales for medicine, medical apparatus and instruments, and health products, he accumulated plenty of operation and management experience from major pharmaceutical enterprises. Mr. Xia has a deep understanding in domestic medical industry development, drug administration regulations, worldwide innovative drugs research tendency, pharmaceutical enterprises operation, merger and acquisition of major pharmaceutical enterprises. 

Mr. Yang Xia  formerly served as the president assistant of Wuhan HumanWell Technology Co., Ltd., general manager of Wuhan Humanwell Sales Co., Ltd., vice president of China Expert Group (US OTCBB), managing director of Beijing ZihuaKangtai Pharmaceutical Co., Ltd., vice general manager of Frost &Sullivan China in charge of medical department, the president assistant of China Resources Dong-E investment Co., Ltd., managing director of Beijing HuaDaJieRui Biotechnology Co., Ltd.